Physician profile
Sunhee Kim
NPI 1033205083
$2,551.15
in general payments reported to CMS, 2019-2025
12 companies · $177 in 2025
The $177 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $123 · 2022: $1,646 · 2023: $283 · 2024: $323 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $782.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $781.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $1,646.38 | 2022 | |
| Pfizer INC. | $303.92 | 2023-2025 | |
| Abbvie INC. | $216.18 | 2023-2025 | |
| Boston Scientific Corporation | $122.85 | 2021 | |
| Biogen, INC. | $73.94 | 2024-2025 | Leqembi, Skyclarys |
| Eisai INC. | $42.07 | 2024-2025 | |
| Ucb, INC. | $38.47 | 2024-2025 | Fintepla, Rystiggo |
| Teva Pharmaceuticals USA, INC. | $28.81 | 2024 | Austedo Xr |
| Inspire Medical Systems, INC. | $25.98 | 2024 | Inspire |
| Novartis Pharmaceuticals Corporation | $21.47 | 2024 | |
| Neurelis, INC. | $15.69 | 2025 | Valtoco |
| Lundbeck LLC | $15.39 | 2024 | Vyepti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunhee Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.